Michael Burgess

We are doubling them, and my bill will also require the CDC to conduct much-needed research on the long-term effects of vaping.

We need to get tough on those who are selling to underage teens.

It's devastating that so many young people and many of their parents are operating under an assumption, oh, that these products are harmless.

I think regulating that at a level of 20 would help to solve this problem with youth addiction.

But the way our system is set up, we can legislate, and we do legislate all the time.

But if someone says--someone who is heavily nicotine addicted--deprivation of nicotine actually incites a fairly significant physiological and psychological response.

I thought that was odd, and I thought that was wrong.

There is potential infringement on the First Amendment by requiring graphic health warnings on cigarette labels and advertising.

Reducing youth tobacco rates is essential to a healthy America.

When it's an issue of public health at stake, it is critical that Congress work with the agencies.

We must help smaller carriers remove suspect equipment for the good of the entire country.

Our bill also establishes a one-billion-dollar reimbursement program to help small carriers remove compromised equipment and replace it with secure alternatives.

I want to thank Ranking Member Walden, Representatives Matsui, and Guthrie for partnering with me to introduce the Secure and Trusted Communications Networks Act.

Everybody on this committee needs to know that we can't do anything that drives innovation to another country like China that could cause us to have a tainted drug supply or that, as one of these articles talks about, pharmaceuticals from…

As a physician, I am uncomfortable with the idea of government action restricting American patients' access to lifesaving medications.

H.R. 3 is a proposal that was drafted behind closed doors by Speaker Pelosi and is being forced through this committee by the chairman.

This committee has a history of working in a bipartisan manner to improve generic and biosimilar competition.

Regrettably, we are holding a quickly assembled partisan hearing on this topic today.

I am uncomfortable with the idea of government action restricting patients' access to lifesaving medications.

I am committed to addressing this issue and lowering out-of-pocket costs for patients.

Every one of us has heard passionate personal stories from our constituents about the ever-increasing costs of prescription drugs.

I think I can speak for other Members of this committee and the American people in saying that we should work together to fix drug prices.

Speaker Pelosi said 'The issue of the cost of prescription drugs is one subject that can make grown men cry,' but how about a cure for a life-threatening illness for your loved one?

I support bipartisan solutions to lower drug prices for American patients.

I think that there is significant danger to children in making that journey.